Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Cancer Research Updates
|
March 18, 2014
Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma
Janet Wangari-Talbot, Elizabeth Hopper-Borge
Pflugers Archiv : European Journal of Physiology
|
July 27, 2006
ABCC10, ABCC11, and ABCC12
Gary D Kruh, Yanping Guo, Elizabeth Hopper-Borge, et al.
Cancer Research
|
July 17, 2004
Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel
Elizabeth Hopper-Borge, Zhe-Sheng Chen, Irina Shchaveleva, et al.
Cancer Research
|
January 2, 2009
Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B
Elizabeth Hopper-Borge, Xiu Xu, Tong Shen, et al.
Molecular Pharmacology
|
January 16, 2003
Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10)
Zhe-Sheng Chen, Elizabeth Hopper-Borge, Martin G Belinsky, et al.
The Journal of Biological Chemistry
|
May 24, 2003
MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine
Yanping Guo, Elena Kotova, Zhe-Sheng Chen, et al.
Journal of Medicinal Chemistry
|
November 25, 2014
Synthesis and biological evaluation of pentacyclic strychnos alkaloids as selective modulators of the ABCC10 (MRP7) efflux pump
Christiana N Teijaro, Surendrachary Munagala, Senzhi Zhao, et al.
Biochemical Pharmacology
|
September 2, 2009
Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance
Ye-Hong Kuang, Tong Shen, Xiang Chen, et al.
Plos One
|
October 21, 2009
Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10)
Tong Shen, Ye-Hong Kuang, Charles R Ashby, et al.
Cancer Research
|
November 1, 2008
The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms
April L Risinger, Evelyn M Jackson, Lisa A Polin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Cancer Research Updates
|
March 18, 2014
Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma
Janet Wangari-Talbot, Elizabeth Hopper-Borge
Pflugers Archiv : European Journal of Physiology
|
July 27, 2006
ABCC10, ABCC11, and ABCC12
Gary D Kruh, Yanping Guo, Elizabeth Hopper-Borge, et al.
Cancer Research
|
July 17, 2004
Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel
Elizabeth Hopper-Borge, Zhe-Sheng Chen, Irina Shchaveleva, et al.
Cancer Research
|
January 2, 2009
Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B
Elizabeth Hopper-Borge, Xiu Xu, Tong Shen, et al.
Molecular Pharmacology
|
January 16, 2003
Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10)
Zhe-Sheng Chen, Elizabeth Hopper-Borge, Martin G Belinsky, et al.
The Journal of Biological Chemistry
|
May 24, 2003
MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine
Yanping Guo, Elena Kotova, Zhe-Sheng Chen, et al.
Journal of Medicinal Chemistry
|
November 25, 2014
Synthesis and biological evaluation of pentacyclic strychnos alkaloids as selective modulators of the ABCC10 (MRP7) efflux pump
Christiana N Teijaro, Surendrachary Munagala, Senzhi Zhao, et al.
Biochemical Pharmacology
|
September 2, 2009
Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance
Ye-Hong Kuang, Tong Shen, Xiang Chen, et al.
Plos One
|
October 21, 2009
Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10)
Tong Shen, Ye-Hong Kuang, Charles R Ashby, et al.
Cancer Research
|
November 1, 2008
The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms
April L Risinger, Evelyn M Jackson, Lisa A Polin, et al.
Page
of 2